tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LGVN Stock Latest News

Longeveron Appoints Dr. George Paletta to Board
Company AnnouncementsLongeveron Appoints Dr. George Paletta to Board
6d ago
8K
LGVN
Longeveron Faces Nasdaq Delisting Notice for Stock Price
PremiumCompany Announcements
Longeveron Faces Nasdaq Delisting Notice for Stock Price
11d ago
8K
LGVN
Longeveron Announces Leadership Changes Amidst CEO Departure
PremiumCompany Announcements
Longeveron Announces Leadership Changes Amidst CEO Departure
1M ago
8K
LGVN
Longeveron CEO Wa’el Hashad to step down
PremiumThe Fly
Longeveron CEO Wa’el Hashad to step down
1M ago
LGVN
Longeveron Inc. Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Longeveron Inc. Earnings Call: Progress Amid Challenges
1M ago
LGVN
Longeveron: Buy Rating Backed by Promising Clinical Developments and Strategic Financial Outlook
PremiumRatingsLongeveron: Buy Rating Backed by Promising Clinical Developments and Strategic Financial Outlook
2M ago
LGVN
Longeveron price target lowered to $3 from $10 at Roth Capital
Premium
The Fly
Longeveron price target lowered to $3 from $10 at Roth Capital
2M ago
LGVN
Longeveron Inc. Faces Regulatory and Manufacturing Challenges Threatening Financial Stability
Premium
Company Announcements
Longeveron Inc. Faces Regulatory and Manufacturing Challenges Threatening Financial Stability
2M ago
LGVN
Longeveron Inc. Reports Q2 2025 Financial Results
PremiumCompany Announcements
Longeveron Inc. Reports Q2 2025 Financial Results
2M ago
LGVN
Longeveron Closes $5 Million Public Stock Offering
PremiumCompany Announcements
Longeveron Closes $5 Million Public Stock Offering
2M ago
8K
LGVN
LGVN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
LGVN Earnings this Week: How Will it Perform?
2M ago
LGVN
Longeveron announces $17.5M Class A common stock offering
PremiumThe Fly
Longeveron announces $17.5M Class A common stock offering
2M ago
LGVN
Longeveron files to sell 3.85M shares of Class A common stock
PremiumThe FlyLongeveron files to sell 3.85M shares of Class A common stock
2M ago
LGVN
Longeveron licenses patent for stem cell technology from University of Miami
Premium
The Fly
Longeveron licenses patent for stem cell technology from University of Miami
3M ago
LGVN
Longeveron Gains FDA Approval for Laromestrocel Trial
Premium
Company Announcements
Longeveron Gains FDA Approval for Laromestrocel Trial
3M ago
8K
LGVN
Longeveron Receives Buy Rating: Promising Pipeline and Strategic Expansion into Pediatric Cardiomyopathy
PremiumRatings
Longeveron Receives Buy Rating: Promising Pipeline and Strategic Expansion into Pediatric Cardiomyopathy
3M ago
LGVN
Longeveron announces FDA approval of IND application for laromestrocel study
PremiumThe Fly
Longeveron announces FDA approval of IND application for laromestrocel study
3M ago
LGVN
Longeveron appoints Powell as Chief Business Officer
PremiumThe Fly
Longeveron appoints Powell as Chief Business Officer
3M ago
LGVN
Positive Buy Rating for Longeveron Driven by Phase 2b Study Milestone and Favorable Market Conditions
PremiumRatings
Positive Buy Rating for Longeveron Driven by Phase 2b Study Milestone and Favorable Market Conditions
3M ago
LGVN
Longeveron completes enrollment of Phase 2b trial of laromestrocel in HLHS
PremiumThe FlyLongeveron completes enrollment of Phase 2b trial of laromestrocel in HLHS
4M ago
LGVN
Longeveron Elects New Director at Annual Meeting
Premium
Company Announcements
Longeveron Elects New Director at Annual Meeting
4M ago
8K
LGVN
Longeveron management to meet with Roth MKM
Premium
The Fly
Longeveron management to meet with Roth MKM
4M ago
LGVN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >